Hyunki Kim joined Stonebridge Ventures in March 2018 and is a managing director whose investment focus is in healthcare. He has considerable experience in biotechnology: he worked at Dong-A biotech Research Center for 8 years as a scientist at Dong-A biosimilars and has served as a senior manager on Global business development team at Dong-A for 3 years. Prior to Stonebridge Ventures, Hyunki worked at NS Investment, a Dong-A affiliate, where he invested global biotech ventures.

Mr. Kim received a B.S. in biotechnology from Sungkyunkawn University and a M.A. in biochemical engineering from Seoul National University. He was a visiting scholar at the University of Minnesota.